▶ 調査レポート

バイオイメージング試薬の世界市場:クラス別、モダリティ別、用途別、エンドユーザー別

• 英文タイトル:Biological Imaging Reagents Market (Class: Contrast Reagents, Optical Reagents, and Nuclear Reagents; Modality: MRI, Ultrasound, X-ray & CT, Nuclear, Optical Imaging, and Others; Application: In Vitro and In Vivo; End User: Diagnostic Laboratories, Imaging Centers, Life Science Companies, Research & Academic Institutes, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Transparency Market Researchが調査・発行した産業分析レポートです。バイオイメージング試薬の世界市場:クラス別、モダリティ別、用途別、エンドユーザー別 / Biological Imaging Reagents Market (Class: Contrast Reagents, Optical Reagents, and Nuclear Reagents; Modality: MRI, Ultrasound, X-ray & CT, Nuclear, Optical Imaging, and Others; Application: In Vitro and In Vivo; End User: Diagnostic Laboratories, Imaging Centers, Life Science Companies, Research & Academic Institutes, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027 / TPM-2JN104資料のイメージです。• レポートコード:TPM-2JN104
• 出版社/出版日:Transparency Market Research / 2019年11月14日
• レポート形態:英文、PDF、232ページ
• 納品方法:Eメール
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥764,940 (USD5,795)▷ お問い合わせ
  Multi User¥1,160,940 (USD8,795)▷ お問い合わせ
  Corporate License¥1,556,940 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートはバイオイメージング試薬の世界市場について調査・分析し、序論、仮定・研究手法、エグゼクティブサマリー、市場状況、市場動向、クラス別分析、モダリティ別分析、用途別分析、エンドユーザー別分析、地域別(北米、欧州、アジア太平洋、中南米、中東・アフリカ)分析、競争状況、企業概要などを含め、次の構成でお届けいたします。
・序論
・仮定・研究手法
・エグゼクティブサマリー
・市場状況
・市場動向
・バイオイメージング試薬の世界市場:クラス別
・バイオイメージング試薬の世界市場:モダリティ別
・バイオイメージング試薬の世界市場:用途別
・バイオイメージング試薬の世界市場:エンドユーザー別
・バイオイメージング試薬の世界市場:地域別(北米、欧州、アジア太平洋、中南米、中東・アフリカ)
・バイオイメージング試薬の北米市場分析・予測
・バイオイメージング試薬の欧州市場分析・予測
・バイオイメージング試薬のアジア太平洋市場分析・予測
・バイオイメージング試薬の中南米市場分析・予測
・バイオイメージング試薬の中東・アフリカ市場分析・予測
・競争状況

The use of nuclear medicine for research and disease treatment dates back to the first half of the 20th century, when they began to be used as tracer elements. Subsequent developments in nuclear medicine and molecular imaging have led to a variety of radiopharmaceutical substances being used for the diagnosis of different diseases. Nuclear imaging modalities such as positron emission tomography (PET) and single-photon emission computerized tomography (SPECT), which use these radiopharmaceuticals, are now being offered as a routine option in the diagnosis and treatment of diseases. With benefits such as better quality of images and precision in the detection of illnesses made possible, particularly in the early detection and diagnosis of cancers, nuclear imaging as a modality within the biological imaging reagents market has been gaining traction in recent years. This modality in the global biological imaging reagents market was valued at ~US$ 2.3 Bn in 2018 and is expected to expand the most among all, at a CAGR of ~9% during the forecast years.

The obvious advantages of multimodal imaging, or multiplexed imaging, over single modality imaging, such as better visualization and more precise images, have contributed significantly to their popularity. The introduction and incorporation of newer technologies and tools, particularly that use multiple imaging techniques, have gained purchase in the larger imaging landscape. For instance, the increased use of PET-SPECT hybrid and PET-MRI imaging systems globally, due to their many benefits, has contributed significantly to the expansion of the biological imaging reagents market.

Manufacturers in the global biological imaging reagents market, focusing on these multimodal techniques, are likely to witness increased potential in the field of research and drug discovery.

The larger imaging landscape has not been immune to the pervasive influence of technology, which has not just caused the industry to progress by leaps and bounds with the development of multimodal imaging techniques, but has also resulted in better prospects for standardized imaging. For instance, the incorporation of AI into molecular imaging is becoming increasingly popular, as the potential for AI to improve diagnostic accuracy is vast, and is only beginning to be explored. With these advancements being incorporated into existing imaging technologies, it has had a significant positive impact on the growth of the biological imaging reagents market.

レポート目次

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Biological Imaging Reagents Market

4. Market Overview

4.1. Introduction

4.1.1. Class Definition

4.1.2. Industry Evolution / Developments

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Biological Imaging Reagents Market Analysis and Forecast, 2017–2027

4.4.1. Market Revenue Projections (US$ Mn)

4.5. Porter’s Five Force Analysis

5. Market Outlook

5.1. Regulatory Scenario by Region/globally

5.2. Technological Advancements

5.3. Disease Prevalence & Incidence Rate globally with key countries

6. Global Biological Imaging Reagents Market Analysis and Forecast, by Class, 2017–2027

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Market Value Forecast, by Class, 2017–2027

6.3.1. Contrast Reagents

6.3.2. Optical Reagents

6.3.3. Nuclear Reagents

6.4. Market Attractiveness, by Class

7. Global Biological Imaging Reagents Market Analysis and Forecast, by Modality, 2017–2027

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Market Value Forecast, by Modality, 2017–2027

7.3.1. MRI

7.3.2. Ultrasound

7.3.3. X-ray & CT

7.3.4. Nuclear

7.3.4.1. PET

7.3.4.2. SPECT

7.3.5. Optical Imaging

7.3.6. Others

7.4. Market Attractiveness, by Modality

8. Global Biological Imaging Reagents Market Analysis and Forecast, by Application

8.1. Introduction & Definition

8.2. Key Findings / Developments

8.3. Market Value Forecast, by Application, 2017–2027

8.3.1. In Vitro

8.3.1.1. Proteomics

8.3.1.2. Genomics

8.3.1.3. Cell Biology

8.3.2. In Vivo

8.4. Market Attractiveness, by Application

9. Global Biological Imaging Reagents Market Analysis and Forecast, by End-user, 2017–2027

9.1. Introduction & Definition

9.2. Key Findings / Developments

9.3. Market Value Forecast, by End-user, 2017–2027

9.3.1. Diagnostic Laboratories

9.3.2. Imaging Centers

9.3.3. Life Sciences Companies

9.3.4. Academic & Research Institutes

9.3.5. Others

9.4. Market Attractiveness, by End-user

10. Global Biological Imaging Reagents Market Analysis and Forecasts, by Region, 2017–2027

10.1. Key Findings

10.2. Market Value Forecast, by Region

10.2.1. North America

10.2.2. Europe

10.2.3. Asia Pacific

10.2.4. Latin America

10.2.5. Middle East & Africa

10.3. Market Attractiveness, by Country/Region

11. North America Biological Imaging Reagents Market Analysis and Forecast, 2017–2027

11.1.Introduction

11.1.1. Key Findings

11.2. Market Value Forecast, by Class, 2017–2027

11.2.1. Contrast Reagents

11.2.2. Optical Reagents

11.2.3. Nuclear Reagents

11.3. Market Value Forecast, by Modality, 2017–2027

11.3.1. MRI

11.3.2. Ultrasound

11.3.3. X-ray & CT

11.3.4. Nuclear

11.3.4.1. PET

11.3.4.2. SPECT

11.3.5. Optical Imaging

11.3.6. Others

11.4. Market Value Forecast, by Application, 2017–2027

11.4.1. In Vitro

11.4.1.1. Proteomics

11.4.1.2. Genomics

11.4.1.3. Cell Biology

11.4.2. In Vivo

11.5. Market Value Forecast, by End-user, 2017–2027

11.5.1. Diagnostic Laboratories

11.5.2. Imaging Centers

11.5.3. Life Sciences Companies

11.5.4. Academic & Research Institutes

11.5.5. Others

11.6. Market Value Forecast, by Country, 2017–2027

11.6.1. U.S.

11.6.2. Canada

11.7. Market Attractiveness Analysis

11.7.1. By Class

11.7.2. By Modality

11.7.3. By Application

11.7.4. By End-user

11.7.5. By Country

12. Europe Biological Imaging Reagents Market Analysis and Forecast, 2017–2027

12.1. Introduction

12.1.1. Key Findings

12.2. Market Value Forecast, by Class, 2017–2027

12.2.1. Contrast Reagents

12.2.2. Optical Reagents

12.2.3. Nuclear Reagents

12.3. Market Value Forecast, by Modality, 2017–2027

12.3.1. MRI

12.3.2. Ultrasound

12.3.3. X-ray & CT

12.3.4. Nuclear

12.3.4.1. PET

12.3.4.2. SPECT

12.3.5. Optical Imaging

12.3.6. Others

12.4. Market Value Forecast, by Application, 2017–2027

12.4.1. In Vitro

12.4.1.1. Proteomics

12.4.1.2. Genomics

12.4.1.3. Cell Biology

12.4.2. In Vivo

12.5. Market Value Forecast, by End-user, 2017–2027

12.5.1. Diagnostic Laboratories

12.5.2. Imaging Centers

12.5.3. Life Sciences Companies

12.5.4. Academic & Research Institutes

12.5.5. Others

12.6. Market Value Forecast, by Country/Sub-region, 2017–2027

12.6.1. Germany

12.6.2. U.K.

12.6.3. France

12.6.4. Spain

12.6.5. Italy

12.6.6. Rest of Europe

12.7. Market Attractiveness Analysis

12.7.1. By Class

12.7.2. By Modality

12.7.3. By Application

12.7.4. By End-user

12.7.5. By Country/Sub-region

13. Asia Pacific Biological Imaging Reagents Market Analysis and Forecast, 2017–2027

13.1. Introduction

13.1.1. Key Findings

13.2. Market Value Forecast, by Class, 2017–2027

13.2.1. Contrast Reagents

13.2.2. Optical Reagents

13.2.3. Nuclear Reagents

13.3. Market Value Forecast, by Modality, 2017–2027

13.3.1. MRI

13.3.2. Ultrasound

13.3.3. X-ray & CT

13.3.4. Nuclear

13.3.4.1. PET

13.3.4.2. SPECT

13.3.5. Optical Imaging

13.3.6. Others

13.4. Market Value Forecast, by Application, 2017–2027

13.4.1. In Vitro

13.4.1.1. Proteomics

13.4.1.2. Genomics

13.4.1.3. Cell Biology

13.4.2. In Vivo

13.5. Market Value Forecast, by End-user, 2017–2027

13.5.1. Diagnostic Laboratories

13.5.2. Imaging Centers

13.5.3. Life Sciences Companies

13.5.4. Academic & Research Institutes

13.5.5. Others

13.6. Market Value Forecast, by Country/Sub-region, 2017–2027

13.6.1. China

13.6.2. Japan

13.6.3. India

13.6.4. Australia & New Zealand

13.6.5. Rest of Asia Pacific

13.7. Market Attractiveness Analysis

13.7.1. By Class

13.7.2. By Modality

13.7.3. By Application

13.7.4. By End-user

13.7.5. By Country/Sub-region

14. Latin America Biological Imaging Reagents Market Analysis and Forecast, 2017–2027

14.1. Introduction

14.1.1. Key Findings

14.2. Market Value Forecast, by Class, 2017–2027

14.2.1. Contrast Reagents

14.2.2. Optical Reagents

14.2.3. Nuclear Reagents

14.3. Market Value Forecast, by Modality, 2017–2027

14.3.1. MRI

14.3.2. Ultrasound

14.3.3. X-ray & CT

14.3.4. Nuclear

14.3.4.1. PET

14.3.4.2. SPECT

14.3.5. Optical Imaging

14.3.6. Others

14.4. Market Value Forecast, by Application, 2017–2027

14.4.1. In Vitro

14.4.1.1. Proteomics

14.4.1.2. Genomics

14.4.1.3. Cell Biology

14.4.2. In Vivo

14.5. Market Value Forecast, by End-user, 2017–2027

14.5.1. Diagnostic Laboratories

14.5.2. Imaging Centers

14.5.3. Life Sciences Companies

14.5.4. Academic & Research Institutes

14.5.5. Others

14.6. Market Value Forecast, by Country/Sub-region, 2017–2027

14.6.1. Brazil

14.6.2. Mexico

14.6.3. Rest of Latin America

14.7. Market Attractiveness Analysis

14.7.1. By Class

14.7.2. By Modality

14.7.3. By Application

14.7.4. By End-user

14.7.5. By Country/Sub-region

15. Middle East & Africa Biological Imaging Reagents Market Analysis and Forecast, 2017–2027

15.1. Introduction

15.1.1. Key Findings

15.2. Market Value Forecast, by Class, 2017–2027

15.2.1. Contrast Reagents

15.2.2. Optical Reagents

15.2.3. Nuclear Reagents

15.3. Market Value Forecast, by Modality, 2017–2027

15.3.1. MRI

15.3.2. Ultrasound

15.3.3. X-ray & CT

15.3.4. Nuclear

15.3.4.1. PET

15.3.4.2. SPECT

15.3.5. Optical Imaging

15.3.6. Others

15.4. Market Value Forecast, by Application, 2017–2027

15.4.1. In Vitro

15.4.1.1. Proteomics

15.4.1.2. Genomics

15.4.1.3. Cell Biology

15.4.2. In Vivo

15.5. Market Value Forecast, by End-user, 2017–2027

15.5.1. Diagnostic Laboratories

15.5.2. Imaging Centers

15.5.3. Life Sciences Companies

15.5.4. Academic & Research Institutes

15.5.5. Others

15.6. Market Value Forecast, by Country/Sub-region, 2017–2027

15.6.1. GCC Countries

15.6.2. South Africa

15.6.3. Rest of Middle East & Africa

15.7. Market Attractiveness Analysis

15.7.1. By Class

15.7.2. By Modality

15.7.3. By Application

15.7.4. By End-user

15.7.5. By Country/Sub-region

16. Competition Landscape

16.1. Market Player – Competition Matrix (By Tier and Size of companies)

16.2. Market Position/Ranking Analysis, by Company (2018)

16.3. Company Profiles

16.3.1. Bayer AG

16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.1.2. Company Financials

16.3.1.3. Growth Strategies

16.3.1.4. SWOT Analysis

16.3.2. Thermo Fisher Scientific, Inc.

16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.2.2. Company Financials

16.3.2.3. Growth Strategies

16.3.2.4. SWOT Analysis

16.3.3. PerkinElmer, Inc.

16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.3.2. Company Financials

16.3.3.3. Growth Strategies

16.3.3.4. SWOT Analysis

16.3.4. Guerbet

16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.4.2. Company Financials

16.3.4.3. Growth Strategies

16.3.4.4. SWOT Analysis

16.3.5. Lantheus Holdings, Inc.

16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.5.2. Company Financials

16.3.5.3. Growth Strategies

16.3.5.4. SWOT Analysis

16.3.6. Bracco S.p.A.

16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.6.2. Company Financials

16.3.6.3. Growth Strategies

16.3.6.4. SWOT Analysis

16.3.7. GE Healthcare

16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.7.2. Company Financials

16.3.7.3. Growth Strategies

16.3.7.4. SWOT Analysis

16.3.8. Becton, Dickinson and Company (BD)

16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.8.2. Company Financials

16.3.8.3. Growth Strategies

16.3.8.4. SWOT Analysis

16.3.9. Siemens Healthineers

16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.9.2. Company Financials

16.3.9.3. Growth Strategies

16.3.9.4. SWOT Analysis

16.3.10. Luminex Corporation

16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.10.2. Company Financials

16.3.10.3. Growth Strategies

16.3.10.4. SWOT Analysis

List of Tables

Table 01: Global Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Class, 2017–2027

Table 02: Global Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Modality, 2017–2027

Table 03: Global Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Nuclear, 2017–2027

Table 04: Global Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 05: Global Biological Imaging Reagents Market Value (US$ Mn) Forecast, by In Vitro, 2017–2027

Table 06: Global Biological Imaging Reagents Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 07: Global Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 08: North America Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 09: North America Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Class, 2017–2027

Table 10: North America Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Modality, 2017–2027

Table 11: North America Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Nuclear, 2017–2027

Table 12: North America Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 13: North America Biological Imaging Reagents Market Value (US$ Mn) Forecast, by In Vitro, 2017–2027

Table 14: North America Biological Imaging Reagents Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 15: Europe Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 16: Europe Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Class, 2017–2027

Table 17: Europe Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Modality, 2017–2027

Table 18: Europe Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Nuclear, 2017–2027

Table 19: Europe Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 20: Europe Biological Imaging Reagents Market Value (US$ Mn) Forecast, by In Vitro, 2017–2027

Table 21: Europe Biological Imaging Reagents Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 22: Asia Pacific Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 23: Asia Pacific Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Class, 2017–2027

Table 24: Asia Pacific Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Modality, 2017–2027

Table 25: Asia Pacific Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Nuclear, 2017–2027

Table 26: Asia Pacific Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 27: Asia Pacific Biological Imaging Reagents Market Value (US$ Mn) Forecast, by In Vitro, 2017–2027

Table 28: Asia Pacific Biological Imaging Reagents Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 29: Latin America Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 30: Latin America Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Class, 2017–2027

Table 31: Latin America Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Modality, 2017–2027

Table 32: Latin America Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Nuclear, 2017–2027

Table 33: Latin America Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 34: Latin America Biological Imaging Reagents Market Value (US$ Mn) Forecast, by In Vitro, 2017–2027

Table 35: Latin America Biological Imaging Reagents Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 36: Middle East & Africa Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 37: Middle East & Africa Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Class, 2017–2027

Table 38: Middle East & Africa Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Modality, 2017–2027

Table 39: Middle East & Africa Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Nuclear, 2017–2027

Table 40: Middle East & Africa Biological Imaging Reagents Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 41: Middle East & Africa Biological Imaging Reagents Market Value (US$ Mn) Forecast, by In Vitro, 2017–2027

Table 42: Middle East & Africa Biological Imaging Reagents Market Value (US$ Mn) Forecast, by End-user, 2017–2027